.png)
.png)
Professor of Medicine
University of North Carolina at Chapel Hill
Disclosure(s): Achaogen: Advisor/Consultant; Allergan: Advisor/Consultant; Astellas: Advisor/Consultant; MedImmune: Advisor/Consultant; Melinta: Advisor/Consultant; Merck: Advisor/Consultant, Grant/Research Support; NeuMedicine: Advisor/Consultant; Pfizer: Advisor/Consultant; Qpex: Advisor/Consultant; Roche: Advisor/Consultant; Sanofi-Pasteur: Advisor/Consultant; Shionogi: Advisor/Consultant, Grant/Research Support; T2 Biosystems: Advisor/Consultant; Tetraphase: Advisor/Consultant
David van Duin, MD, PhD, FIDSA, FAST. Professor in the Infectious Diseases Division at the University of North Carolina. Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are infections caused by multi-drug resistant Gram-negative bacteria, especially carbapenem-resistant Enterobacteriaceae, and infections in immunocompromised patients.